These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2658458)

  • 41. Comparison of postoperative respiratory function after laparoscopy or open laparotomy for cholecystectomy.
    Putensen-Himmer G; Putensen C; Lammer H; Lingnau W; Aigner F; Benzer H
    Anesthesiology; 1992 Oct; 77(4):675-80. PubMed ID: 1416164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral acetylcysteine in cystic fibrosis. A co-operative study.
    Götz M; Kraemer R; Kerrebijn KF; Popow C
    Eur J Respir Dis Suppl; 1980; 111():122-6. PubMed ID: 7011832
    [No Abstract]   [Full Text] [Related]  

  • 43. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C
    Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
    Brocard H; Charpin J; Germouty J
    Eur J Respir Dis Suppl; 1980; 111():65-9. PubMed ID: 7011834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials.
    Ballantyne JC; Carr DB; deFerranti S; Suarez T; Lau J; Chalmers TC; Angelillo IF; Mosteller F
    Anesth Analg; 1998 Mar; 86(3):598-612. PubMed ID: 9495424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.
    Ratjen F; Wönne R; Posselt HG; Stöver B; Hofmann D; Bender SW
    Eur J Pediatr; 1985 Nov; 144(4):374-8. PubMed ID: 3908111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind parallel study of acetylcysteine-isoproterenol and saline-isoproterenol in patients with chronic obstructive lung disease.
    Cato A; Goldstein I; Millman M
    J Int Med Res; 1977; 5(3):175-83. PubMed ID: 330289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of ventilation/perfusion ratio map in surgical patients by dual-energy CT after xenon inhalation and intravenous contrast media.
    Aoki K; Izumi Y; Watanabe W; Shimizu Y; Osada H; Honda N; Itoh T; Nakayama M
    J Cardiothorac Surg; 2018 May; 13(1):43. PubMed ID: 29776385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test.
    Shohrati M; Aslani J; Eshraghi M; Alaedini F; Ghanei M
    Respir Med; 2008 Mar; 102(3):443-8. PubMed ID: 18036807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
    Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Smith TW; Antman EM
    Circulation; 1988 Apr; 77(4):787-94. PubMed ID: 3127076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.
    Conrad C; Lymp J; Thompson V; Dunn C; Davies Z; Chatfield B; Nichols D; Clancy J; Vender R; Egan ME; Quittell L; Michelson P; Antony V; Spahr J; Rubenstein RC; Moss RB; Herzenberg LA; Goss CH; Tirouvanziam R
    J Cyst Fibros; 2015 Mar; 14(2):219-27. PubMed ID: 25228446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo.
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153
    [No Abstract]   [Full Text] [Related]  

  • 54. Improvement of 'dynamic analgesia' does not decrease atelectasis after thoracotomy.
    Boisseau N; Rabary O; Padovani B; Staccini P; Mouroux J; Grimaud D; Raucoules-Aimé M
    Br J Anaesth; 2001 Oct; 87(4):564-9. PubMed ID: 11878725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine.
    Laurent T; Markert M; Feihl F; Schaller MD; Perret C
    Chest; 1996 Jan; 109(1):163-6. PubMed ID: 8549180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic high-dose oral-N-acetylcysteine does not prevent atrial fibrillation after heart surgery: a prospective double blind placebo-controlled randomized clinical trial.
    Kazemi B; Akbarzadeh F; Safaei N; Yaghoubi A; Shadvar K; Ghasemi K
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1211-9. PubMed ID: 23731362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
    Takeda S; Funakoshi Y; Kadota Y; Koma M; Maeda H; Kawamura S; Matsubara Y
    Ann Thorac Surg; 2006 Jul; 82(1):232-6. PubMed ID: 16798220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass.
    Ulas MM; Hizarci M; Kunt A; Ergun K; Kocabeyoglu SS; Korkmaz K; Lafci G; Gedik S; Cagli K
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):518-23. PubMed ID: 19034033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
    Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
    Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.